In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.

Ítems similars

• Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors
  per: Hess, EJ, et al.
  Publicat: (1988)
• Pharmacology of the Atypical Antipsychotic Remoxipride, a Dopamine D(2) Receptor Antagonist
  per: Nadal, Roser
  Publicat: (2006)
• The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists
  per: Kalani, M. Yashar S., et al.
  Publicat: (2004)
• The Affinity of D(2)-Like Dopamine Receptor Antagonists Determines the Time to Maximal Effect on Cocaine Self-Administration
  per: Norman, Andrew B., et al.
  Publicat: (2011)
• A Review of the Discovery, Pharmacological Characterization, and Behavioral Effects of the Dopamine D2‐Like Receptor Antagonist Eticlopride
  per: Martelle, Jennifer L., et al.
  Publicat: (2008)